Maya Desai


How Can Pharma Companies Join the Digital Therapeutics Revolution?

More and more companies are joining forces with software developers to create innovative products. But many are learning the hard way that making next-generation digital therapeutics isn’t as easy as signing a partnership agreement.

New Standards for First-to-Launch Players

While COVID-19 has shifted some of the rules, research reveals that practice changes were already afoot for market newcomers.

Research Reveals New Launch Standards for First-to-Launch Pharma and Biotech Companies in the U.S.

While COVID-19 has shifted the rules of the healthcare industry, research shows there was already progress on changes being made for how pharma companies are launching products.